The Ozempic Era Will Force the Travel Industry to Adapt
Skift Take
If travel companies are not thinking about the impact of GLP-1s on their bottom line yet – in 2024 they will.
Subscribe now for complete access to Skift.com's trusted coverage of the travel industry.
Already a subscriber? Login